The residents were surprised by the result of Yeouido rally “10,000 people participated voluntarily”
[2020 South Korean Doctors] The residents were surprised by the result of Yeouido rally “10,000 people participated voluntarily” The Korean Intern and Resident Association(KIRA) proceeded with ‘the first young doctor’s group action’ rally opposing the government’s policy of increasing medical school admission quotas in Yeouido park from 2pm to 5pm on Aug 7. On this day, the walkout rally of the residents attracted great attention, as more residents gathered than expected and the start time was delayed for more than 40 minu
"A struggle against the policy of increasing medical school admission quotas"
[2020 South Korean Doctors] "A struggle against the policy of increasing medical school admission quotas"...the fourth year students of 40 medical schools and medical graduate schools nationwide, the participation rate refusing to takethe national examination is 88.9% The fourth-year students of medical schoolsand medical graduate schools nationwide are pushing against taking the national examination following after the refusal of classes and practices in opposition to increase medical school admission quotas and the estab
"We won’t withdraw our strike, unless the government withdraws and reconsiders the plans."
[2020 South Korean Doctors] The participation rateof the strike by the Korean resident doctors is 69.4%..." We won’t withdraw our strike, unless the government withdraws and reconsiders the plans." With ongoing strikesby the Korean resident doctors from Aug. 23,it was shown that seven of ten have participated in the strike. The residents said they will withdraw the strike if the government withdraw and reconsider the policy of increasing the number of medical students.On Aug. 24, the Ministry of Health and Welfarestated ba
An average monthly salary of an internal medicine doctor in Seoul is $9948, a weekly working hours are 49.1 hours
http://data.medigate.net/salary [관련기사=서울 지역 내과의사 평균 월급은 1193만원, 주당 근무시간은 49.1시간] Doctor:Gate- Salary Index, you can check on your salary level and working hours when entering the region•department•working hours. [MedigateNews] MediC&C, #1 Doctor community in Korea, has launched a data-based service, ‘Doctor:Gate(http://data.medigate.net/)’, for medical professionals and doctor members. Doctor:Gate-salary index provides the information on the level of salary and working hours based on information
Amlodipine decreased and Amlodipine•Besylate combination increased for treating hypertension over 6 year
http://data.medigate.net/search [관련기사=6년간 고혈압약 처방 암로디핀 줄고, 암로디핀·발사르탄 복합제 늘고] DOCTOR:GATE-prescription information provides the information over 6 years from 2013~2018 on frequently prescribed medication and market share of each disease [MedigateNews] MediC&C, which runs the No.1 doctors’ community, Medigate, has opened a new data base service called Doctorgate (http://data.medigate.net/) for the medical professionals as well as its members. What is the most prescribed drug for 'hypertension' in
“Lynparza, Best-in-Class as well as First-in-Class"
[Medical Team’s Medicine Story] ④ Astrazeneca Korea Medical Team, Joohwan Lee Astrazeneca Korea Medical Team, Joohwan Lee. [MedigateNews] The BRCA gene repairs damaged DNA, preventing normal cells from developing into tumors. BRCA mutations affect the development of breast cancer, ovarian cancer, pancreatic cancer, and prostate cancer. Angelina Jolie, who has a family history of breast cancer and ovarian cancer, underwent a preventive operation in breast and ovary in 2013 and 2015 respectively, after discovering that the BRCA1 gene had a mutation in the BRCA test. Linparz
"Biktarvy, the best of the best HIV medicine that has been developed by Gilead Sciences"
[Medical Team’s Medicine Story] ③ Gilead Science Korea Medical Team, Jung Ah Lee Gilead Science Korea Medical Team, Jung Ah Lee. [MedigateNews] The HIV, previously called incurable disease, has become a disease that can be managed like a chronic disease if medication is continuously taken. The current treatment trend globally is to recommend the initiation of treatment as early as possible in the early stages of HIV infection and the use of second-generation Integrase Strand Transfer Inhibitor (InSTI) as antiretroviral therapy. Gilead Sciences launched ‘Truvada’ that is appr
"With Alprolix, we will open up new changes to the patients with hemophilia B"
[Drug story of a medical team]② Hyosun Shin, Director at Sanofi Genzyme Hyosun Shin, Director of Rare Blood Disease Division at Sanofi Genzyme [MedigateNews] Hemophilia is a congenital blood clotting disease in which hemostasis is delayed due to the absence or lack of some of the blood coagulation factors involved in hemostasis. The main clinical feature is joint bleeding. If the joint bleeding is repeated, the joint is damaged and cartilage is eroded, leading to complications called hemophilic arthrosis in the long term. In addition, if bleeding suddenly occurs in
Adcetris presents new paradigm for cutaneous cell lymphoma treatment with ADC technology
[Drug story of a medical team]① Yeaji Kim, MSL of Takeda Pharmaceutical Korea Yeaji Kim, MSL of Medical Division, Takeda Pharmaceutical Korea. [MedigateNews] Lymphoma is rare in kind, but it is a disease in which treatment results drop rapidly when relapsing, and is largely divided into Hodgkin lymphoma and non-Hodgkin lymphoma. 5% of all lymphomas are Hodgkin's lymphomas and the rest are non-Hodgkin's lymphomas. Adcetris(Brentuximab vedotin), a drug for the treatment of lymphoma of Takeda Pharmaceutical Company, has six indications for each subtype of Hodgkin's lymphoma
The reason why Korean investors paid attention to 'Hummingbird Bioscience'
Dr. Piers Ingram, CEO and co-founder of Hummingbird Bioscience Piers Ingram CEO "Development of innovative targeted therapeutics with a system biology-based approach and technology platform" [관련기사=SK 등 한국 투자자들이 싱가포르 바이오벤처 '허밍버드 바이오사이언스'에 주목한 이유는] Singapore bio-venture company Hummingbird Bioscience received an additional investment of approximately 8 billion won(about 6.5 million USD) in May of this year following the attraction of Series B investment of 27.2 billion won(19 million USD) last Dec
전체 뉴스 순위